CorneaGen
  • SURGEON PORTAL
  • Contact Us
  • CORNEAL TISSUE
    • Tissue Overview
    • Tissue Services
      • DSAEK
      • DMEK
      • Pre-Loaded DMEK
      • Ampho B
      • PKP
      • ALK
      • BrightMEM
      • FLAK
      • Non-Sterile Sclera
    • Tissue Reimbursement
    • Adverse Reaction Reporting
    • Regulatory Information
    • Request Tissue
  • Sterile Tissue
    • CTAK
    • VisionGraft
      • Glaucoma
      • Cornea
    • Sclera
    • Reimbursement
      • CTAK Reimbursement
      • VisionGraft Reimbursement
    • Adverse Reaction Reporting
    • Regulatory Information
  • CTAK
    • CTAK Overview
    • CTAK International
    • CTAK Reimbursement
  • Products
    • Products Overview
    • EndoSerter-PL
    • EndoSerter
    • Cannula
    • DescePro System
    • Donor Punch
    • Recipient Trephine
  • Education
    • Online Training
    • Educational Videos
    • Wet Labs
    • Fellows Program
  • About Us
    • Our People
    • Our Partners
    • Our Locations
    • Reimbursement
    • Gift of Sight
    • Insights & Updates
    • Core Commitments
    • Innovation
    • Careers
Request Tissue & Products Contact Us
CTAK Update from ASCRS 2024

CTAK Update from ASCRS 2024

May 15, 2024

Hear from Dr. Steven Greenstein and Dr. Peter Hersh from the ASCRS show floor about CTAK, the latest innovation for the treatment of keratoconus.

 

Recent Articles

  • Growing for Greater Impact: CorneaGen Expands in Orlando to Better Serve Surgeons and Patients

    Growing for Greater Impact: CorneaGen Expands in Orlando to Better Serve Surgeons and Patients

    CorneaGen is excited to share that our expanded Orlando facility is now fully operational,...

    READ MORE
  • CEO Update – September 2025

    CEO Update – September 2025

    As we transition into fall after a fast-paced summer, CorneaGen’s...

    READ MORE

  • CTAK Expands Surgeon Access: Procedure Now Compatible with Ziemer GALILEI platform  

    CTAK Expands Surgeon Access: Procedure Now Compatible with Ziemer GALILEI...

    READ MORE
  • CEO Update – June 2025

    CEO Update – June 2025

    A message from Bernie Iliakis, President & CEO of CorneaGen...

    READ MORE
Navigation
  • Corneal Tissue
  • Sterile Tissue
  • CTAK
  • Products
  • Education
  • About Us
  • Request Tissue
Helpful Information
  • Reimbursement assistance
  • Adverse reaction reporting
  • Regulatory Information
  • KAMRA Support
  • Careers
Legal
  • Privacy Policy
  • Proprietary Terms and conditions
  • Regulatory Information
  • Vendor Information
  • Billing Terms and Conditions
  • Purchase Order Terms and Conditions
Connect
  • Contact Us
CorneaGen

©2025 CorneaGen

CorneaGen